Lung Transplant Clinical Trial
Official title:
A Prospective Multicenter Observational Cohort Study to Define the Risks Factors, Mechanisms, and Manifestations of Chronic Lung Allograft Dysfunction (CLAD) Phenotypes (CTOT-20)
While many patients experience benefits from transplant, complications such as infections and
lung rejection may affect long term survival and quality of life. In this study doctors are
looking at a complication called Chronic Lung Allograft Dysfunction (CLAD). CLAD is thought
to be chronic rejection of the lung by the immune system and is the leading cause of death
after lung transplantation.
The purpose of this study is to help doctors determine:
- why some people get CLAD and others do not
- how patients who get CLAD do after CLAD is diagnosed
- how CLAD may affect quality of life
This is an observational, prospective, multicenter study of newly transplanted adult, first lung transplant recipients that will collect longitudinal clinical data, patient reported quality of life (QOL) data, and serial biological samples to determine the risk factors, pathophysiology, and manifestations of restrictive chronic lung allograft dysfunction (RCLAD) and bronchiolitis obliterans syndrome (BOS). Anticipated participant accrual is within three years of study start‐up. The total study duration is four years. Participants will be followed a minimum of 1 and a maximum of 4 years. ;
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Recruiting |
NCT05404919 -
Utilization of Hepatitis B Virus NAT+ Donors for Hepatitis B Vaccinated Lung Transplant Candidates
|
Phase 2 | |
| Completed |
NCT03299504 -
Factors Predicting Success in Lung Transplant Recipients Who Have Undergone Intensive Post-operative Rehabilitation
|
||
| Completed |
NCT00755781 -
Study of Cyclosporine Inhalation Solution (CIS) in Improving Bronchiolitis Obliterans Syndrome-Free Survival Following Lung Transplantation
|
Phase 3 | |
| Recruiting |
NCT05547698 -
A Study of Venoarterial ECMO vs Off-Pump Bilateral Orthotopic Lung Transplantation
|
N/A | |
| Terminated |
NCT03207399 -
Lung Transplantation in Chronic HCV Infection With Post Transplant EPCLUSA Treatment
|
Phase 4 | |
| Completed |
NCT03300882 -
PREDICT Cytomegalovirus (CMV)
|
||
| Recruiting |
NCT05101460 -
An All Comers Registry For Normothermic Ex Vivo Lung Perfusion (EVLP) as Assessment of Donor Lungs for Transplant
|
||
| Completed |
NCT03150095 -
Health Coaching to Improve Self-Management in Thoracic Transplant Candidates
|
N/A | |
| Completed |
NCT04420195 -
Envarsus XR in Lung Transplant
|
Phase 2 | |
| Recruiting |
NCT02235610 -
Use of Ex Vivo Lung Perfusion (EVLP) in Reconditioning Marginal Donor Lungs for Transplantation
|
N/A | |
| Not yet recruiting |
NCT06066229 -
Identification of Patient Important Outcomes in Lung Transplantation
|
||
| Recruiting |
NCT04601818 -
Planned Semi-Elective Lung Tx Study
|
N/A | |
| Recruiting |
NCT03072589 -
Study to Evaluate Adenosine 2A Receptor Agonist (Regadenoson) in Patients Undergoing Lung Transplantation
|
Phase 1 | |
| Completed |
NCT01963780 -
International EXPAND Lung Pivotal Trial
|
N/A | |
| Recruiting |
NCT05671887 -
DREAM: Double Lung Transplant REgistry Aimed for Lung-limited Malignancies
|
||
| Completed |
NCT03987113 -
Impact of Cold Ischemia on Pulmonary Endothelial Dysfunction in Ex-vivo Pulmonary Reconditioning
|
||
| Recruiting |
NCT02748798 -
Developing Optimal Parameters for Hyperpolarized Noble Gas and Inert Fluorinated Gas MRI of Lung Disorders
|
Early Phase 1 | |
| Completed |
NCT03167528 -
Contribution of Learning and Practice of Different Complementary Therapies in Pulmonary Transplant Patients
|
N/A | |
| Active, not recruiting |
NCT04244734 -
Implementation of an Early Rehabilitation Program for the Patient With Lung Transplantation: From the ICU to Home.
|
N/A | |
| Active, not recruiting |
NCT01365429 -
Novel Lung Trial: Normothermic Ex Vivo Lung Perfusion (Evlp) As An Assessment Of Extended/Marginal Donor Lungs
|
N/A |